An Inverse‐Selection‐Probability Weighted Approach for Real‐World Progression‐Free Survival With Left‐Truncated Clinico‐Genomic Data
ABSTRACT Next‐generation sequencing (NGS) has become a vital tool in precision medicine, revolutionizing cancer diagnosis and treatment. However, in real‐world studies where NGS defines study entry, data are often left‐truncated because patients who do not survive until sequencing are excluded. Consequently, standard s...